50% of mice in the BMA-OVA + anti-Gr1 Ab treatment group completely rejected their primary tumors and 3LL-OVA tumor cells (2×105) on re-challenge.
收藏Figshare2015-12-02 更新2026-04-29 收录
下载链接：
https://figshare.com/articles/dataset/_50_of_mice_in_the_BMA_OVA_anti_Gr1_Ab_treatment_group_completely_rejected_their_primary_tumors_and_3LL_OVA_tumor_cells_2_10_5_on_re_challenge_/280024
下载链接
链接失效反馈官方服务：
资源简介：
50% of mice in the BMA-OVA + anti-Gr1 Ab treatment group completely rejected their primary tumors and 3LL-OVA tumor cells (2×105) on re-challenge.
创建时间：
2015-12-02
